Cargando…
Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies.
5-Aminolaevulinic acid (ALA)-induced prophyrin photosensitisation is an attractive option for photodynamic therapy (PDT) since skin photosensitivity is limited to 1-2 days. However, early clinical results on colon tumours using the maximum tolerated oral dose of 60 mg kg-1 showed only superficial ne...
Autores principales: | Messmann, H., Mlkvy, P., Buonaccorsi, G., Davies, C. L., MacRobert, A. J., Bown, S. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033889/ https://www.ncbi.nlm.nih.gov/pubmed/7669566 |
Ejemplares similares
-
Photodynamic therapy on the normal rabbit larynx with phthalocyanine and 5-aminolaevulinic acid induced protoporphyrin IX photosensitisation.
por: Kleemann, D., et al.
Publicado: (1996) -
Photodynamic therapy of normal rat arteries after photosensitisation using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid.
por: Grant, W. E., et al.
Publicado: (1994) -
Enhancement of 5-aminolaevulinic acid-induced photodynamic therapy in normal rat colon using hydroxypyridinone iron-chelating agents.
por: Curnow, A., et al.
Publicado: (1998) -
Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993) -
Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.
por: Regula, J., et al.
Publicado: (1994)